SDGR
Schrödinger, Inc.
Industry
Medical - Healthcare Information Services
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Loading...
Open
20.83
Mkt cap
1.6B
Volume
311K
High
21.96
P/E Ratio
-8.82
52-wk high
38.00
Low
20.33
Div yield
N/A
52-wk low
16.67

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.